Pain Therapeutics, Durect take a beating over US FDA rejection of Remoxy
27 June 2011
Donna Young
Please Login to read the full article.
27 June 2011
Donna Young
donna.young@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Zogenix seeks US FDA OK for single-entity hydrocodone in lucrative pain market
- BDSI CEO: Shared fentanyl REMS puts Onsolis on level playing field
- Janssen wins US FDA nod for chronic pain drug Nucynta ER
- FDA accepts Endo's harder-to-abuse Opana ER application, with six-month review set
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
